Anti Viral Therapies Market Scope And Analysis

  • Report Code : TIPRE00012650
  • Category : Life Sciences
  • No. of Pages : 170
Buy Now

Anti-Viral Therapies Market Scope and Growth by 2031

Buy Now

Anti-Viral Therapies Market Report Scope

Report Attribute Details
Market size in 2024 US$ 60.16 Billion
Market Size by 2031 US$ 105.80 Billion
Global CAGR (2025 - 2031) 8.40%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Generic Drugs and Branded Drugs
By Mechanism of Action
  • Nucleotide Polymerase Inhibitor
  • Reverse Transcriptase Inhibitors
  • Protease Inhibitors
By and Application
  • HIV
  • Hepatitis
  • Virus Influenza
  • Herpes
  • Other Applications
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc
  • Abbott
  • F Hoffmann La Roche Ltd
  • Bristol Myers Squibb Company
  • Johnson Johnson Services Inc
  • Merck and Co Inc
  • Gilead Sciences Inc
  • GlaxoSmithKline plc
  • Aurobindo Pharma